25 XP   0   0   10

IRIDEX Corporation
Buy, Hold or Sell?

Let's analyse Iridex together

PenkeI guess you are interested in IRIDEX Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IRIDEX Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IRIDEX Corporation

I send you an email if I find something interesting about IRIDEX Corporation.

Quick analysis of Iridex (30 sec.)










What can you expect buying and holding a share of Iridex? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.59
Expected worth in 1 year
$0.11
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.47
Return On Investment
-16.1%

For what price can you sell your share?

Current Price per Share
$2.94
Expected price per share
$1.89 - $3.65
How sure are you?
50%

1. Valuation of Iridex (5 min.)




Live pricePrice per Share (EOD)

$2.94

Intrinsic Value Per Share

$-3.61 - $-1.75

Total Value Per Share

$-3.02 - $-1.16

2. Growth of Iridex (5 min.)




Is Iridex growing?

Current yearPrevious yearGrowGrow %
How rich?$9.5m$19m-$6.2m-49.4%

How much money is Iridex making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m-$1.8m-$505.7k-21.1%
Net Profit Margin-18.5%-13.4%--

How much money comes from the company's main activities?

3. Financial Health of Iridex (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#234 / 334

Most Revenue
#175 / 334

Most Profit
#176 / 334

Most Efficient
#170 / 334

What can you expect buying and holding a share of Iridex? (5 min.)

Welcome investor! Iridex's management wants to use your money to grow the business. In return you get a share of Iridex.

What can you expect buying and holding a share of Iridex?

First you should know what it really means to hold a share of Iridex. And how you can make/lose money.

Speculation

The Price per Share of Iridex is $2.94. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Iridex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Iridex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.59. Based on the TTM, the Book Value Change Per Share is $-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Iridex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.18-6.2%-0.15-5.0%-0.12-3.9%-0.12-3.9%-0.12-4.0%
Usd Book Value Change Per Share-0.16-5.3%-0.12-4.0%-0.09-3.2%-0.06-2.1%-0.03-0.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-5.3%-0.12-4.0%-0.09-3.2%-0.06-2.1%-0.03-0.9%
Usd Price Per Share2.81-2.39-2.91-3.51-6.37-
Price to Earnings Ratio-3.86--4.22--6.30--7.60-8.39-
Price-to-Total Gains Ratio-17.97--21.68--31.94--2.27--930.92-
Price to Book Ratio4.80-3.23-2.44-2.80-3.71-
Price-to-Total Gains Ratio-17.97--21.68--31.94--2.27--930.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.94
Number of shares340
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.12-0.06
Usd Total Gains Per Share-0.12-0.06
Gains per Quarter (340 shares)-40.32-21.38
Gains per Year (340 shares)-161.27-85.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-161-1710-86-96
20-323-3320-171-182
30-484-4930-257-268
40-645-6540-342-354
50-806-8150-428-440
60-968-9760-513-526
70-1129-11370-599-612
80-1290-12980-684-698
90-1451-14590-770-784
100-1613-16200-855-870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%8.032.00.020.0%61.049.00.055.5%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%12.028.00.030.0%63.045.02.057.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0110.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%3.017.00.015.0%12.028.00.030.0%63.045.02.057.3%

Fundamentals of Iridex

About IRIDEX Corporation

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Fundamental data was last updated by Penke on 2024-04-11 12:11:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of IRIDEX Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Iridex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • A Net Profit Margin of -23.8% means that $-0.24 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IRIDEX Corporation:

  • The MRQ is -23.8%. The company is making a huge loss. -2
  • The TTM is -18.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23.8%TTM-18.5%-5.2%
TTM-18.5%YOY-13.4%-5.1%
TTM-18.5%5Y-16.6%-1.9%
5Y-16.6%10Y-12.8%-3.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.8%-12.4%-11.4%
TTM-18.5%-20.4%+1.9%
YOY-13.4%-14.8%+1.4%
5Y-16.6%-21.3%+4.7%
10Y-12.8%-25.0%+12.2%
1.1.2. Return on Assets

Shows how efficient Iridex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • -8.6% Return on Assets means that Iridex generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IRIDEX Corporation:

  • The MRQ is -8.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-6.6%-2.0%
TTM-6.6%YOY-4.1%-2.4%
TTM-6.6%5Y-4.9%-1.6%
5Y-4.9%10Y-3.5%-1.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-4.1%-4.5%
TTM-6.6%-4.7%-1.9%
YOY-4.1%-4.8%+0.7%
5Y-4.9%-4.0%-0.9%
10Y-3.5%-5.2%+1.7%
1.1.3. Return on Equity

Shows how efficient Iridex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • -31.1% Return on Equity means Iridex generated $-0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IRIDEX Corporation:

  • The MRQ is -31.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.1%TTM-19.8%-11.2%
TTM-19.8%YOY-9.8%-10.0%
TTM-19.8%5Y-10.4%-9.4%
5Y-10.4%10Y-6.6%-3.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.1%-4.2%-26.9%
TTM-19.8%-5.8%-14.0%
YOY-9.8%-5.7%-4.1%
5Y-10.4%-6.3%-4.1%
10Y-6.6%-7.1%+0.5%

1.2. Operating Efficiency of IRIDEX Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Iridex is operating .

  • Measures how much profit Iridex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • An Operating Margin of -24.7% means the company generated $-0.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IRIDEX Corporation:

  • The MRQ is -24.7%. The company is operating very inefficient. -2
  • The TTM is -21.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24.7%TTM-21.1%-3.7%
TTM-21.1%YOY-15.1%-5.9%
TTM-21.1%5Y-19.2%-1.9%
5Y-19.2%10Y-16.3%-2.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.7%-24.3%-0.4%
TTM-21.1%-16.4%-4.7%
YOY-15.1%-13.7%-1.4%
5Y-19.2%-19.9%+0.7%
10Y-16.3%-24.5%+8.2%
1.2.2. Operating Ratio

Measures how efficient Iridex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.25 means that the operating costs are $1.25 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IRIDEX Corporation:

  • The MRQ is 1.247. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.194. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.247TTM1.194+0.054
TTM1.194YOY1.134+0.060
TTM1.1945Y1.178+0.015
5Y1.17810Y1.149+0.029
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2471.442-0.195
TTM1.1941.439-0.245
YOY1.1341.431-0.297
5Y1.1781.436-0.258
10Y1.1491.374-0.225

1.3. Liquidity of IRIDEX Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Iridex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.12 means the company has $2.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IRIDEX Corporation:

  • The MRQ is 2.116. The company is able to pay all its short-term debts. +1
  • The TTM is 2.481. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.116TTM2.481-0.366
TTM2.481YOY3.052-0.571
TTM2.4815Y3.120-0.639
5Y3.12010Y3.820-0.700
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1162.726-0.610
TTM2.4812.732-0.251
YOY3.0523.510-0.458
5Y3.1203.617-0.497
10Y3.8203.499+0.321
1.3.2. Quick Ratio

Measures if Iridex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • A Quick Ratio of 1.29 means the company can pay off $1.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IRIDEX Corporation:

  • The MRQ is 1.286. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.505. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.286TTM1.505-0.219
TTM1.505YOY2.113-0.608
TTM1.5055Y2.210-0.705
5Y2.21010Y2.638-0.428
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2861.491-0.205
TTM1.5051.633-0.128
YOY2.1132.1130.000
5Y2.2102.295-0.085
10Y2.6382.255+0.383

1.4. Solvency of IRIDEX Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Iridex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Iridex to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.72 means that Iridex assets are financed with 72.3% credit (debt) and the remaining percentage (100% - 72.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IRIDEX Corporation:

  • The MRQ is 0.723. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.723TTM0.657+0.067
TTM0.657YOY0.580+0.076
TTM0.6575Y0.485+0.171
5Y0.48510Y0.349+0.136
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7230.389+0.334
TTM0.6570.386+0.271
YOY0.5800.335+0.245
5Y0.4850.442+0.043
10Y0.3490.461-0.112
1.4.2. Debt to Equity Ratio

Measures if Iridex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Iridex to the Medical Devices industry mean.
  • A Debt to Equity ratio of 261.6% means that company has $2.62 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IRIDEX Corporation:

  • The MRQ is 2.616. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.960. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.616TTM1.960+0.657
TTM1.960YOY1.386+0.574
TTM1.9605Y1.079+0.881
5Y1.07910Y0.676+0.402
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6160.551+2.065
TTM1.9600.554+1.406
YOY1.3860.479+0.907
5Y1.0790.622+0.457
10Y0.6760.674+0.002

2. Market Valuation of IRIDEX Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Iridex generates.

  • Above 15 is considered overpriced but always compare Iridex to the Medical Devices industry mean.
  • A PE ratio of -3.86 means the investor is paying $-3.86 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IRIDEX Corporation:

  • The EOD is -4.036. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.857. Based on the earnings, the company is expensive. -2
  • The TTM is -4.219. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.036MRQ-3.857-0.178
MRQ-3.857TTM-4.219+0.362
TTM-4.219YOY-6.296+2.077
TTM-4.2195Y-7.596+3.377
5Y-7.59610Y8.394-15.990
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.036-1.077-2.959
MRQ-3.857-1.704-2.153
TTM-4.219-2.081-2.138
YOY-6.296-2.978-3.318
5Y-7.596-2.379-5.217
10Y8.394-1.726+10.120
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IRIDEX Corporation:

  • The EOD is -12.614. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.057. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.018. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.614MRQ-12.057-0.558
MRQ-12.057TTM-7.018-5.039
TTM-7.018YOY-4.757-2.261
TTM-7.0185Y-11.476+4.458
5Y-11.47610Y-6.364-5.112
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-12.614-0.932-11.682
MRQ-12.057-1.578-10.479
TTM-7.018-2.973-4.045
YOY-4.757-6.318+1.561
5Y-11.476-5.307-6.169
10Y-6.364-5.171-1.193
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Iridex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.80 means the investor is paying $4.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IRIDEX Corporation:

  • The EOD is 5.018. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.796. Based on the equity, the company is fair priced.
  • The TTM is 3.229. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.018MRQ4.796+0.222
MRQ4.796TTM3.229+1.567
TTM3.229YOY2.435+0.794
TTM3.2295Y2.804+0.425
5Y2.80410Y3.714-0.910
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.0181.876+3.142
MRQ4.7962.372+2.424
TTM3.2292.434+0.795
YOY2.4353.217-0.782
5Y2.8043.893-1.089
10Y3.7144.245-0.531
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IRIDEX Corporation.

3.1. Institutions holding IRIDEX Corporation

Institutions are holding 20.125% of the shares of IRIDEX Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31PARAGON Assoc & PARAGON Assoc II JV6.15476.445100000000
2023-12-31Vanguard Group Inc3.4294055719900
2023-12-31Renaissance Technologies Corp2.55460.001841506020000.4842
2023-12-31AMH Equity Ltd2.43730.9994396000-241103-37.8436
2023-12-31Geode Capital Management, LLC0.7428012069489327.992
2023-12-31Schmeidler A R & CO Inc0.67540.03421097423825053.5025
2023-12-31Susquehanna International Group, LLP0.6530.000110609653961103.5024
2023-12-31Long Focus Capital Management, LLC0.61550.009310000000
2023-12-31Bridgeway Capital Management, LLC0.47450.00477710000
2023-12-31Apexium Financial, LP0.40430.01336569500
2023-12-31BlackRock Inc0.343905587130125.6982
2023-12-31Dimensional Fund Advisors, Inc.0.2974048327-30441-38.6464
2023-12-31State Street Corporation0.275204471800
2023-12-31Perkins Capital Management Inc0.24680.096540100-150-0.3727
2023-12-31Bank of New York Mellon Corp0.213503469300
2023-12-31Northern Trust Corp0.1745028354-10659-27.3217
2023-12-31Wolverine Trading LLC0.10730.000117434-13605-43.832
2023-12-31XTX Topco Ltd0.09070.009114729147290
2023-12-31HighTower Advisors, LLC0.06150.00011000000
2023-12-31UBS Group AG0.04180679167910
Total 19.99417.61363248603-168283-5.2%

3.2. Funds holding IRIDEX Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.31930.000137694400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.00980.000416411300
2023-12-31Bridgeway Ultra-Small Company Market0.46150.11347500000
2024-02-29Fidelity Extended Market Index0.40070.000565120-316-0.4829
2024-03-28iShares Micro-Cap ETF0.19320.01023139400
2024-03-29Dimensional US Small Cap ETF0.13460.00082188300
2024-02-29Fidelity Nasdaq Composite Index0.09990.00031623700
2024-02-29Fidelity Series Total Market Index0.09880.00011606500
2024-02-29Fidelity Total Market Index0.089101447500
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06670.00051084100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05770.0005937400
2023-12-31Northern Trust Extended Eq Market Idx0.05770.0005937400
2024-02-29Vanguard Balanced Index Inv0.05520897400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05360.00058707160.1841
2024-03-29Dimensional US Core Equity 2 ETF0.04740.0001770000
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04370.0001710200
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.04370.00017102-365945-98.0962
2024-02-29Spartan Total Market Index Pool E0.03260.0001529800
2023-12-31NT Quality SCC US Fund - L0.03080.00565004-368-6.8503
2023-12-31NT Quality Small Cap Core0.03080.00595004-368-6.8503
Total 5.32680.1397865711-366981-42.4%

3.3. Insider Transactions

Insiders are holding 24.996% of the shares of IRIDEX Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-05-20Nandini DeviBUY20003.1
2021-12-02Robert Earle GroveBUY16446.08
2021-11-16Nandini DeviBUY10007.73

4. Summary

4.1. Key Performance Indicators

The key performance indicators of IRIDEX Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.156-0.119-24%-0.093-40%-0.063-60%-0.025-84%
Book Value Per Share--0.5860.783-25%1.170-50%1.238-53%1.611-64%
Current Ratio--2.1162.481-15%3.052-31%3.120-32%3.820-45%
Debt To Asset Ratio--0.7230.657+10%0.580+25%0.485+49%0.349+107%
Debt To Equity Ratio--2.6161.960+33%1.386+89%1.079+143%0.676+287%
Dividend Per Share----0%-0%-0%-0%
Eps---0.182-0.147-19%-0.116-36%-0.115-37%-0.116-36%
Free Cash Flow Per Share---0.058-0.105+81%-0.151+159%-0.062+6%-0.050-13%
Free Cash Flow To Equity Per Share---0.055-0.106+90%-0.153+176%-0.026-54%0.003-2199%
Gross Profit Margin--2.3062.769-17%3.643-37%3.548-35%1.647+40%
Intrinsic Value_10Y_max---1.750--------
Intrinsic Value_10Y_min---3.609--------
Intrinsic Value_1Y_max---0.177--------
Intrinsic Value_1Y_min---0.231--------
Intrinsic Value_3Y_max---0.531--------
Intrinsic Value_3Y_min---0.810--------
Intrinsic Value_5Y_max---0.884--------
Intrinsic Value_5Y_min---1.515--------
Market Cap47783232.000+4%45670368.00038803560.000+18%47214384.000-3%56997386.200-20%103550060.300-56%
Net Profit Margin---0.238-0.185-22%-0.134-43%-0.166-30%-0.128-46%
Operating Margin---0.247-0.211-15%-0.151-39%-0.192-22%-0.163-34%
Operating Ratio--1.2471.194+4%1.134+10%1.178+6%1.149+9%
Pb Ratio5.018+4%4.7963.229+49%2.435+97%2.804+71%3.714+29%
Pe Ratio-4.036-5%-3.857-4.219+9%-6.296+63%-7.596+97%8.394-146%
Price Per Share2.940+4%2.8102.388+18%2.905-3%3.506-20%6.371-56%
Price To Free Cash Flow Ratio-12.614-5%-12.057-7.018-42%-4.757-61%-11.476-5%-6.364-47%
Price To Total Gains Ratio-18.797-5%-17.966-21.684+21%-31.941+78%-2.269-87%-930.916+5081%
Quick Ratio--1.2861.505-15%2.113-39%2.210-42%2.638-51%
Return On Assets---0.086-0.066-24%-0.041-52%-0.049-43%-0.035-60%
Return On Equity---0.311-0.198-36%-0.098-68%-0.104-66%-0.066-79%
Total Gains Per Share---0.156-0.119-24%-0.093-40%-0.063-60%-0.025-84%
Usd Book Value--9522000.00012730000.000-25%19016000.000-50%20123000.000-53%26182900.000-64%
Usd Book Value Change Per Share---0.156-0.119-24%-0.093-40%-0.063-60%-0.025-84%
Usd Book Value Per Share--0.5860.783-25%1.170-50%1.238-53%1.611-64%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.182-0.147-19%-0.116-36%-0.115-37%-0.116-36%
Usd Free Cash Flow---947000.000-1713500.000+81%-2451250.000+159%-1001500.000+6%-820825.000-13%
Usd Free Cash Flow Per Share---0.058-0.105+81%-0.151+159%-0.062+6%-0.050-13%
Usd Free Cash Flow To Equity Per Share---0.055-0.106+90%-0.153+176%-0.026-54%0.003-2199%
Usd Market Cap47783232.000+4%45670368.00038803560.000+18%47214384.000-3%56997386.200-20%103550060.300-56%
Usd Price Per Share2.940+4%2.8102.388+18%2.905-3%3.506-20%6.371-56%
Usd Profit---2960000.000-2392500.000-19%-1886750.000-36%-1874200.000-37%-1396175.000-53%
Usd Revenue--12458000.00012967250.000-4%14243000.000-13%12126900.000+3%11461050.000+9%
Usd Total Gains Per Share---0.156-0.119-24%-0.093-40%-0.063-60%-0.025-84%
 EOD+5 -3MRQTTM+10 -24YOY+8 -265Y+6 -2810Y+6 -28

4.2. Fundamental Score

Let's check the fundamental score of IRIDEX Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.036
Price to Book Ratio (EOD)Between0-15.018
Net Profit Margin (MRQ)Greater than0-0.238
Operating Margin (MRQ)Greater than0-0.247
Quick Ratio (MRQ)Greater than11.286
Current Ratio (MRQ)Greater than12.116
Debt to Asset Ratio (MRQ)Less than10.723
Debt to Equity Ratio (MRQ)Less than12.616
Return on Equity (MRQ)Greater than0.15-0.311
Return on Assets (MRQ)Greater than0.05-0.086
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of IRIDEX Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.596
Ma 20Greater thanMa 503.124
Ma 50Greater thanMa 1002.782
Ma 100Greater thanMa 2002.778
OpenGreater thanClose3.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets34,436
Total Liabilities24,914
Total Stockholder Equity9,522
 As reported
Total Liabilities 24,914
Total Stockholder Equity+ 9,522
Total Assets = 34,436

Assets

Total Assets34,436
Total Current Assets27,450
Long-term Assets6,986
Total Current Assets
Cash And Cash Equivalents 7,034
Net Receivables 9,654
Inventory 9,906
Other Current Assets 856
Total Current Assets  (as reported)27,450
Total Current Assets  (calculated)27,450
+/-0
Long-term Assets
Property Plant Equipment 2,983
Goodwill 965
Intangible Assets 1,642
Long-term Assets Other 1,396
Long-term Assets  (as reported)6,986
Long-term Assets  (calculated)6,986
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,974
Long-term Liabilities11,940
Total Stockholder Equity9,522
Total Current Liabilities
Short-term Debt 995
Accounts payable 4,499
Other Current Liabilities 5,076
Total Current Liabilities  (as reported)12,974
Total Current Liabilities  (calculated)10,570
+/- 2,404
Long-term Liabilities
Capital Lease Obligations 2,746
Long-term Liabilities Other 26
Long-term Liabilities  (as reported)11,940
Long-term Liabilities  (calculated)2,772
+/- 9,168
Total Stockholder Equity
Common Stock172
Retained Earnings -79,042
Accumulated Other Comprehensive Income -52
Other Stockholders Equity 88,444
Total Stockholder Equity (as reported)9,522
Total Stockholder Equity (calculated)9,522
+/-0
Other
Capital Stock172
Cash and Short Term Investments 7,034
Common Stock Shares Outstanding 16,245
Current Deferred Revenue2,404
Liabilities and Stockholders Equity 34,436
Net Debt -4,288
Net Invested Capital 9,522
Net Working Capital 14,476
Property Plant and Equipment Gross 16,723
Short Long Term Debt Total 2,746



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-31
> Total Assets 
0
0
0
6,400
0
22,300
22,500
23,700
23,000
24,700
25,400
26,700
27,700
27,900
27,800
28,380
28,400
29,400
30,100
32,665
33,208
34,645
35,301
35,025
32,003
32,304
32,639
33,788
32,632
32,582
33,438
34,272
34,532
34,031
34,473
35,874
35,839
36,917
37,655
39,090
39,093
39,683
40,937
41,104
41,104
41,530
41,529
40,177
40,180
64,423
60,550
46,650
46,654
38,879
35,756
28,230
28,225
26,917
27,324
28,291
25,428
26,648
28,200
29,220
29,304
29,876
30,866
32,149
30,919
31,292
30,439
28,912
29,152
31,370
32,038
33,677
32,981
32,264
32,579
41,820
41,818
41,167
40,651
41,823
42,363
43,745
42,714
48,144
47,428
45,786
43,610
41,646
37,212
35,143
43,537
41,672
40,667
38,485
35,958
34,813
30,896
29,275
28,459
27,969
49,559
50,520
50,542
48,687
48,024
45,646
44,959
42,290
40,980
36,939
34,949
34,436
34,43634,94936,93940,98042,29044,95945,64648,02448,68750,54250,52049,55927,96928,45929,27530,89634,81335,95838,48540,66741,67243,53735,14337,21241,64643,61045,78647,42848,14442,71443,74542,36341,82340,65141,16741,81841,82032,57932,26432,98133,67732,03831,37029,15228,91230,43931,29230,91932,14930,86629,87629,30429,22028,20026,64825,42828,29127,32426,91728,22528,23035,75638,87946,65446,65060,55064,42340,18040,17741,52941,53041,10441,10440,93739,68339,09339,09037,65536,91735,83935,87434,47334,03134,53234,27233,43832,58232,63233,78832,63932,30432,00335,02535,30134,64533,20832,66530,10029,40028,40028,38027,80027,90027,70026,70025,40024,70023,00023,70022,50022,30006,400000
   > Total Current Assets 
0
0
0
6,000
0
20,800
21,900
17,800
18,000
22,800
23,300
24,500
25,400
25,600
25,400
25,940
25,900
27,000
27,800
29,003
29,653
31,002
31,747
31,530
28,503
28,930
29,412
30,329
29,282
29,363
29,887
31,055
31,437
31,035
31,544
33,556
33,467
34,604
34,754
32,650
32,652
37,613
38,827
38,917
38,917
39,380
39,382
37,866
37,870
34,718
33,414
35,500
35,503
29,333
26,980
25,690
25,690
24,675
25,187
26,329
23,596
23,647
25,252
26,372
26,486
27,154
28,020
29,506
28,606
29,034
28,613
27,055
27,392
29,688
30,364
31,970
31,289
30,460
30,772
32,890
32,894
31,933
31,424
30,769
31,378
32,672
31,406
45,865
45,020
43,519
41,481
39,451
34,909
32,933
41,372
39,618
35,059
33,283
31,218
30,551
26,975
25,763
25,561
25,359
44,221
43,731
43,906
42,253
41,929
39,444
38,349
35,766
34,698
30,965
27,342
27,450
27,45027,34230,96534,69835,76638,34939,44441,92942,25343,90643,73144,22125,35925,56125,76326,97530,55131,21833,28335,05939,61841,37232,93334,90939,45141,48143,51945,02045,86531,40632,67231,37830,76931,42431,93332,89432,89030,77230,46031,28931,97030,36429,68827,39227,05528,61329,03428,60629,50628,02027,15426,48626,37225,25223,64723,59626,32925,18724,67525,69025,69026,98029,33335,50335,50033,41434,71837,87037,86639,38239,38038,91738,91738,82737,61332,65232,65034,75434,60433,46733,55631,54431,03531,43731,05529,88729,36329,28230,32929,41228,93028,50331,53031,74731,00229,65329,00327,80027,00025,90025,94025,40025,60025,40024,50023,30022,80018,00017,80021,90020,80006,000000
       Cash And Cash Equivalents 
0
0
0
1,200
0
15,400
14,500
5,000
4,300
10,000
9,400
9,900
10,200
5,800
2,500
5,790
5,800
8,700
10,200
9,645
10,935
11,694
10,650
9,998
7,548
7,756
5,723
4,613
5,856
6,351
7,375
9,186
11,888
8,121
7,800
9,477
10,541
7,744
8,612
10,380
10,381
10,482
11,055
12,655
12,655
3,740
3,738
21,051
21,050
9,568
5,795
5,810
5,809
4,092
2,974
5,310
5,307
6,618
7,884
9,378
6,365
7,000
7,092
9,014
8,569
8,875
9,535
10,789
13,856
13,785
13,734
11,901
11,581
13,505
14,089
13,444
13,969
12,862
13,042
13,300
13,303
12,203
10,213
9,995
10,514
11,521
9,577
23,747
23,858
24,594
22,751
21,707
18,522
16,045
23,725
21,194
17,175
15,633
12,948
12,653
11,139
11,624
11,932
11,626
27,993
26,259
25,568
23,852
20,621
17,966
15,856
13,922
11,048
9,821
7,981
7,034
7,0347,9819,82111,04813,92215,85617,96620,62123,85225,56826,25927,99311,62611,93211,62411,13912,65312,94815,63317,17521,19423,72516,04518,52221,70722,75124,59423,85823,7479,57711,52110,5149,99510,21312,20313,30313,30013,04212,86213,96913,44414,08913,50511,58111,90113,73413,78513,85610,7899,5358,8758,5699,0147,0927,0006,3659,3787,8846,6185,3075,3102,9744,0925,8095,8105,7959,56821,05021,0513,7383,74012,65512,65511,05510,48210,38110,3808,6127,74410,5419,4777,8008,12111,8889,1867,3756,3515,8564,6135,7237,7567,5489,99810,65011,69410,9359,64510,2008,7005,8005,7902,5005,80010,2009,9009,40010,0004,3005,00014,50015,40001,200000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,230
7,700
5,090
5,090
3,300
2,800
3,503
2,699
1,835
3,000
2,996
4,256
3,272
4,496
4,489
2,428
3,680
3,075
2,356
1,418
5,016
7,142
7,438
5,751
10,736
9,511
3,320
3,323
8,211
9,017
8,779
8,779
18,540
18,540
18,540
0
3,800
3,800
3,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000003,8003,8003,800018,54018,54018,5408,7798,7799,0178,2113,3233,3209,51110,7365,7517,4387,1425,0161,4182,3563,0753,6802,4284,4894,4963,2724,2562,9963,0001,8352,6993,5032,8003,3005,0905,0907,7005,2300000000000000
       Net Receivables 
0
0
0
2,500
0
2,600
3,200
5,400
5,000
5,100
5,500
6,100
7,100
7,500
7,500
7,610
7,600
6,800
6,500
8,162
8,211
8,654
8,640
8,010
6,536
6,861
6,592
8,066
7,939
6,952
7,290
8,037
6,385
6,389
6,225
5,825
6,548
5,926
6,516
7,400
7,404
7,177
6,857
6,589
6,589
6,040
6,035
6,052
6,050
9,688
8,516
8,880
8,876
9,061
9,215
8,200
8,199
7,354
7,148
7,482
7,651
6,616
7,954
7,526
8,119
7,468
7,738
5,551
5,142
5,924
5,496
5,480
6,031
6,148
5,743
7,345
6,732
7,259
7,578
8,340
8,337
7,319
7,736
9,282
9,297
8,450
7,926
10,025
8,866
7,049
7,390
7,863
6,400
7,142
8,430
9,083
8,417
8,083
8,784
9,323
6,987
5,784
6,083
7,289
8,185
8,599
8,522
9,716
10,451
9,237
9,744
9,768
10,759
8,799
8,114
9,654
9,6548,1148,79910,7599,7689,7449,23710,4519,7168,5228,5998,1857,2896,0835,7846,9879,3238,7848,0838,4179,0838,4307,1426,4007,8637,3907,0498,86610,0257,9268,4509,2979,2827,7367,3198,3378,3407,5787,2596,7327,3455,7436,1486,0315,4805,4965,9245,1425,5517,7387,4688,1197,5267,9546,6167,6517,4827,1487,3548,1998,2009,2159,0618,8768,8808,5169,6886,0506,0526,0356,0406,5896,5896,8577,1777,4047,4006,5165,9266,5485,8256,2256,3896,3858,0377,2906,9527,9398,0666,5926,8616,5368,0108,6408,6548,2118,1626,5006,8007,6007,6107,5007,5007,1006,1005,5005,1005,0005,4003,2002,60002,500000
       Other Current Assets 
0
0
0
1,000
0
900
1,900
5,500
6,600
5,100
5,100
4,500
3,600
6,200
8,600
950
6,000
900
1,100
437
458
493
442
805
895
590
540
600
690
540
420
751
1,130
1,105
930
2,346
972
1,902
1,710
2,622
2,622
2,782
2,571
2,300
2,300
2,192
2,192
1,264
2,218
2,218
5,853
1,051
4,851
983
1,264
540
540
598
489
470
546
552
424
620
601
642
571
6,507
2,570
1,786
1,841
1,129
1,123
1,095
534
576
730
586
548
510
510
615
666
386
425
560
1,225
450
568
488
671
500
681
653
492
547
766
593
590
401
691
508
542
730
1,001
911
1,025
1,071
1,766
2,065
1,984
1,468
1,650
1,216
1,129
856
8561,1291,2161,6501,4681,9842,0651,7661,0711,0259111,0017305425086914015905937665474926536815006714885684501,2255604253866666155105105485867305765341,0951,1231,1291,8411,7862,5706,5075716426016204245525464704895985405401,2649834,8511,0515,8532,2182,2181,2642,1922,1922,3002,3002,5712,7822,6222,6221,7101,9029722,3469301,1051,1307514205406906005405908958054424934584371,1009006,0009508,6006,2003,6004,5005,1005,1006,6005,5001,90090001,000000
   > Long-term Assets 
0
0
0
400
0
1,500
600
5,900
5,000
1,900
2,100
2,200
2,300
2,300
2,400
2,440
2,500
2,400
2,300
3,662
3,555
3,643
3,554
3,495
3,500
3,374
3,227
3,459
3,350
3,219
3,551
3,217
3,095
2,996
2,929
2,318
2,372
2,313
2,901
0
6,441
2,070
2,110
0
2,187
0
2,147
2,311
2,310
29,705
27,136
0
11,151
9,546
8,776
0
2,535
2,242
2,137
1,962
1,832
3,001
2,948
2,848
2,818
2,722
2,846
2,643
2,313
2,258
1,826
1,857
1,760
1,682
1,674
1,707
1,692
1,804
1,807
8,924
8,924
9,234
9,227
11,054
10,985
11,073
11,308
2,279
2,408
2,267
2,129
2,195
2,303
2,210
2,165
2,054
5,608
5,202
4,740
4,262
3,921
3,512
2,898
2,610
5,338
6,789
6,636
6,434
6,095
6,202
6,610
6,524
6,282
5,974
7,607
6,986
6,9867,6075,9746,2826,5246,6106,2026,0956,4346,6366,7895,3382,6102,8983,5123,9214,2624,7405,2025,6082,0542,1652,2102,3032,1952,1292,2672,4082,27911,30811,07310,98511,0549,2279,2348,9248,9241,8071,8041,6921,7071,6741,6821,7601,8571,8262,2582,3132,6432,8462,7222,8182,8482,9483,0011,8321,9622,1372,2422,53508,7769,54611,151027,13629,7052,3102,3112,14702,18702,1102,0706,44102,9012,3132,3722,3182,9292,9963,0953,2173,5513,2193,3503,4593,2273,3743,5003,4953,5543,6433,5553,6622,3002,4002,5002,4402,4002,3002,3002,2002,1001,9005,0005,9006001,5000400000
       Property Plant Equipment 
0
0
0
300
0
500
500
700
600
800
2,100
2,100
2,300
2,300
2,400
2,270
2,300
2,200
2,200
2,144
2,037
2,125
2,036
1,903
1,908
1,782
1,635
1,535
1,418
1,287
1,072
950
828
729
662
796
850
791
772
852
852
805
845
1,114
1,114
1,048
1,048
1,087
1,789
1,789
1,840
1,621
1,621
1,284
1,128
832
832
595
547
486
433
386
395
360
325
299
316
325
378
388
468
483
440
432
526
543
575
720
748
735
735
1,079
1,089
1,104
1,055
1,188
1,447
1,534
1,672
1,561
1,428
1,403
1,488
1,396
1,312
1,220
4,790
4,381
3,932
3,494
3,168
2,745
2,144
1,877
1,947
3,467
3,361
2,993
2,695
2,529
2,297
2,127
1,872
1,535
3,313
2,983
2,9833,3131,5351,8722,1272,2972,5292,6952,9933,3613,4671,9471,8772,1442,7453,1683,4943,9324,3814,7901,2201,3121,3961,4881,4031,4281,5611,6721,5341,4471,1881,0551,1041,0891,0797357357487205755435264324404834683883783253162993253603953864334865475958328321,1281,2841,6211,6211,8401,7891,7891,0871,0481,0481,1141,1148458058528527727918507966627298289501,0721,2871,4181,5351,6351,7821,9081,9032,0362,1252,0372,1442,2002,2002,3002,2702,4002,3002,3002,1002,1008006007005005000300000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,751
11,751
10,509
3,240
3,239
3,239
3,239
0
0
0
0
0
0
473
473
473
473
473
533
533
533
533
533
533
533
533
533
533
533
533
533
530
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
533
965
965
965
965
965
965
965
965
965
965
965
965
9659659659659659659659659659659659655335335335335335335335335335335335335335335335335335335335335335335335335305335335335335335335335335335335335335334734734734734730000003,2393,2393,2393,24010,50911,75111,751000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
40
40
100
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,841
15,841
14,488
5,940
5,944
4,771
4,185
1,470
1,474
1,313
1,233
1,153
1,098
1,892
1,846
1,797
1,749
1,701
1,772
745
700
653
602
554
489
437
382
328
296
292
288
280
284
276
272
268
264
260
256
132
128
124
120
116
112
108
104
100
96
92
88
84
80
76
72
68
2,349
2,301
2,253
2,205
2,157
2,109
2,061
1,977
1,894
1,810
1,726
1,642
1,6421,7261,8101,8941,9772,0612,1092,1572,2052,2532,3012,34968727680848892961001041081121161201241281322562602642682722762842802882922963283824374895546026537007451,7721,7011,7491,7971,8461,8921,0981,1531,2331,3131,4741,4704,1854,7715,9445,94014,48815,84115,8410000000000000000000000000000010010010010040400000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,518
1,518
1,518
1,592
1,592
1,592
1,592
1,924
1,932
1,932
2,479
2,267
2,267
2,267
2,267
1,522
1,522
1,522
2,129
5,589
2,800
1,265
1,265
1,073
1,073
1,099
1,179
1,224
27,916
25,447
25,296
9,530
8,879
8,262
7,648
1,703
1,704
1,647
1,590
1,476
1,399
2,615
2,553
2,488
2,493
2,423
2,530
2,318
1,935
1,870
1,358
1,374
1,320
1,250
1,148
1,164
1,117
1,084
1,059
8,189
8,024
8,155
8,138
9,950
9,930
9,885
9,861
745
736
706
701
143
170
173
216
201
189
196
187
151
140
158
149
1,560
77
56
57
271
278
599
1,287
1,455
0
1,664
0
0
001,66401,4551,2875992782715756771,5601491581401511871961892012161731701437017067367459,8619,8859,9309,9508,1388,1558,0248,1891,0591,0841,1171,1641,1481,2501,3201,3741,3581,8701,9352,3182,5302,4232,4932,4882,5532,6151,3991,4761,5901,6471,7041,7037,6488,2628,8799,53025,29625,44727,9161,2241,1791,0991,0731,0731,2651,2652,8005,5892,1291,5221,5221,5222,2672,2672,2672,2672,4791,9321,9321,9241,5921,5921,5921,5921,5181,5181,51800000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,151
7,001
7,151
7,149
8,985
8,985
8,985
8,985
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000008,9858,9858,9858,9857,1497,1517,0017,1510000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1,700
0
1,600
1,600
2,200
1,300
2,500
2,400
2,800
3,100
2,700
2,400
2,490
2,500
3,200
3,500
5,161
4,848
5,460
5,281
4,525
3,217
3,479
3,529
3,955
2,900
3,288
3,852
4,074
4,397
4,197
4,307
4,358
5,005
5,117
6,352
7,310
7,310
7,195
7,123
6,587
6,587
5,880
5,884
8,020
8,020
34,153
26,107
27,840
27,844
20,460
17,571
16,480
16,479
13,347
12,999
13,265
9,779
9,277
9,780
9,793
9,395
8,704
9,283
9,723
6,658
6,525
6,678
7,007
6,025
7,144
6,960
7,823
6,413
6,545
6,958
8,080
8,082
7,936
7,831
8,135
8,174
9,229
8,162
8,984
7,584
8,196
8,508
11,124
9,957
10,710
10,928
11,711
13,224
12,856
11,970
12,108
9,747
10,481
11,207
10,603
23,910
23,640
25,220
25,388
26,698
26,214
26,884
25,059
25,096
23,489
22,885
24,914
24,91422,88523,48925,09625,05926,88426,21426,69825,38825,22023,64023,91010,60311,20710,4819,74712,10811,97012,85613,22411,71110,92810,7109,95711,1248,5088,1967,5848,9848,1629,2298,1748,1357,8317,9368,0828,0806,9586,5456,4137,8236,9607,1446,0257,0076,6786,5256,6589,7239,2838,7049,3959,7939,7809,2779,77913,26512,99913,34716,47916,48017,57120,46027,84427,84026,10734,1538,0208,0205,8845,8806,5876,5877,1237,1957,3107,3106,3525,1175,0054,3584,3074,1974,3974,0743,8523,2882,9003,9553,5293,4793,2174,5255,2815,4604,8485,1613,5003,2002,5002,4902,4002,7003,1002,8002,4002,5001,3002,2001,6001,60001,700000
   > Total Current Liabilities 
0
0
0
1,700
0
1,600
1,600
2,200
1,300
2,500
2,400
2,800
3,100
2,700
2,500
2,490
2,500
3,200
3,500
5,161
4,848
5,460
5,281
4,525
3,217
3,479
3,529
3,955
2,900
3,288
3,852
4,074
4,397
4,197
4,307
4,358
5,005
5,117
6,352
7,310
7,310
7,195
7,123
6,587
6,587
5,880
5,884
8,020
8,020
34,153
26,107
27,840
27,844
20,460
17,571
16,480
16,479
13,347
12,999
13,116
9,597
8,704
9,195
9,197
8,790
8,094
8,507
8,913
5,939
5,876
5,972
6,367
5,483
6,683
6,519
7,362
6,071
6,200
6,513
7,040
7,039
7,055
7,145
7,431
7,535
8,663
7,543
8,461
7,169
7,754
7,712
10,392
9,255
10,035
10,390
11,088
9,647
9,768
9,299
9,778
7,835
7,575
9,213
8,681
12,747
10,922
12,967
12,646
12,588
12,352
13,633
12,453
13,162
12,235
10,348
12,974
12,97410,34812,23513,16212,45313,63312,35212,58812,64612,96710,92212,7478,6819,2137,5757,8359,7789,2999,7689,64711,08810,39010,0359,25510,3927,7127,7547,1698,4617,5438,6637,5357,4317,1457,0557,0397,0406,5136,2006,0717,3626,5196,6835,4836,3675,9725,8765,9398,9138,5078,0948,7909,1979,1958,7049,59713,11612,99913,34716,47916,48017,57120,46027,84427,84026,10734,1538,0208,0205,8845,8806,5876,5877,1237,1957,3107,3106,3525,1175,0054,3584,3074,1974,3974,0743,8523,2882,9003,9553,5293,4793,2174,5255,2815,4604,8485,1613,5003,2002,5002,4902,5002,7003,1002,8002,4002,5001,3002,2001,6001,60001,700000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,137
11,137
10,421
4,860
9,879
6,000
6,000
6,000
6,000
4,478
3,500
3,520
3,520
0
0
0
0
0
0
3,342
3,229
2,858
3,515
207
0
0
0
3,043
0
0
0
0
2,920
0
0
441
0
3,588
3,196
590
0
0
0
566
0
0
0
697
1,334
1,363
1,388
1,414
1,430
2,555
2,913
2,658
3,530
854
920
927
938
994
1,012
1,037
1,046
1,049
995
995
9959951,0491,0461,0371,0129949389279208543,5302,6582,9132,5551,4301,4141,3881,3631,3346970005660005903,1963,5880441002,92000003,0430002073,5152,8583,2293,3420000003,5203,5203,5004,4786,0006,0006,0006,0009,8794,86010,42111,13711,137000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,334
0
0
0
0
1,110
1,526
1,249
2,185
0
0
0
0
0
0
0
0
0
0
0
000000000002,1851,2491,5261,11000001,334000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
300
0
600
400
500
400
800
1,000
800
1,000
800
900
880
900
600
600
1,128
1,144
2,022
1,671
1,408
1,264
1,570
1,339
1,176
598
729
795
657
996
892
876
708
1,029
939
950
1,233
1,233
1,150
1,188
1,094
1,094
1,356
1,356
1,830
5,460
5,460
3,552
2,887
2,887
3,728
2,593
2,415
2,415
1,389
1,314
1,872
2,226
2,013
2,381
1,981
2,007
2,099
2,222
1,580
1,544
2,139
1,529
2,105
1,280
2,573
2,077
2,278
1,770
2,008
1,842
5,860
1,758
2,060
2,559
2,223
2,696
3,194
2,472
1,994
1,944
1,781
1,864
1,724
1,976
2,243
2,552
2,516
2,400
2,196
2,429
2,592
1,501
557
1,475
1,148
1,687
2,249
3,208
3,399
3,454
3,812
4,539
3,873
3,546
4,278
2,613
4,499
4,4992,6134,2783,5463,8734,5393,8123,4543,3993,2082,2491,6871,1481,4755571,5012,5922,4292,1962,4002,5162,5522,2431,9761,7241,8641,7811,9441,9942,4723,1942,6962,2232,5592,0601,7585,8601,8422,0081,7702,2782,0772,5731,2802,1051,5292,1391,5441,5802,2222,0992,0071,9812,3812,0132,2261,8721,3141,3892,4152,4152,5933,7282,8872,8873,5525,4605,4601,8301,3561,3561,0941,0941,1881,1501,2331,2339509391,0297088768929966577957295981,1761,3391,5701,2641,4081,6712,0221,1441,1286006009008809008001,0008001,0008004005004006000300000
       Other Current Liabilities 
0
0
0
1,400
0
1,000
1,200
1,700
900
1,700
1,400
2,000
2,100
1,900
1,600
1,610
1,600
2,600
2,900
4,033
3,704
3,438
3,610
3,117
1,953
1,909
2,190
2,779
2,302
2,559
3,057
3,417
3,401
3,305
3,431
3,005
3,380
3,452
4,613
5,294
5,167
4,666
4,693
4,941
4,421
4,528
3,304
4,775
17,556
13,871
8,157
14,875
11,728
7,601
6,173
7,898
5,323
4,802
5,472
5,319
4,950
4,425
4,575
5,082
4,561
3,820
4,153
2,860
259
79
67
3,051
3,260
3,092
3,380
908
3,217
3,109
3,496
1,179
1,182
3,796
3,375
3,456
3,528
610
570
4,494
3,864
4,628
4,445
5,582
5,034
5,476
5,621
5,650
4,171
4,695
3,954
4,322
3,522
3,241
3,753
3,937
5,718
5,814
6,589
5,965
5,840
5,179
5,651
5,132
6,146
4,598
4,501
5,076
5,0764,5014,5986,1465,1325,6515,1795,8405,9656,5895,8145,7183,9373,7533,2413,5224,3223,9544,6954,1715,6505,6215,4765,0345,5824,4454,6283,8644,4945706103,5283,4563,3753,7961,1821,1793,4963,1093,2179083,3803,0923,2603,05167792592,8604,1533,8204,5615,0824,5754,4254,9505,3195,4724,8025,3237,8986,1737,60111,72814,8758,15713,87117,5564,7753,3044,5284,4214,9414,6934,6665,1675,2944,6133,4523,3803,0053,4313,3053,4013,4173,0572,5592,3022,7792,1901,9091,9533,1173,6103,4383,7044,0332,9002,6001,6001,6101,6001,9002,1002,0001,4001,7009001,7001,2001,00001,400000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,380
0
0
0
4,058
4,666
4,269
0
0
0
0
0
0
13,871
0
0
0
0
0
0
0
0
0
149
182
573
585
596
605
610
776
810
719
649
706
640
542
461
441
461
342
345
445
1,043
1,043
881
686
704
639
566
619
523
415
442
796
732
702
675
538
623
3,577
3,088
2,671
2,330
1,912
2,906
1,994
1,922
11,163
12,718
12,253
12,742
14,110
13,862
13,251
12,606
11,934
11,254
12,537
11,940
11,94012,53711,25411,93412,60613,25113,86214,11012,74212,25312,71811,1631,9221,9942,9061,9122,3302,6713,0883,5776235386757027327964424155236195666397046868811,0431,04344534534246144146154264070664971981077661060559658557318214900000000013,8710000004,2694,6664,0580003,380000000000000000000000-10000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,387
971
1,248
312
0
0
0
0
0
0
0
0
0
0
0
000000000003121,2489711,38700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,151
7,001
7,151
7,149
8,985
8,985
8,985
8,985
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000008,9858,9858,9858,9857,1497,1517,0017,1510000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
149
182
573
585
596
605
610
776
810
719
649
706
640
542
461
441
461
342
345
445
1,043
1,026
881
686
704
639
566
619
523
415
442
796
732
702
675
538
623
709
572
520
535
476
451
407
392
10,756
10,582
10,281
11,013
12,631
12,640
12,290
11,874
0
11,044
0
0
0011,044011,87412,29012,64012,63111,01310,28110,58210,7563924074514765355205727096235386757027327964424155236195666397046868811,0261,04344534534246144146154264070664971981077661060559658557318214900000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
4,700
0
20,700
20,900
21,500
21,700
22,200
23,000
23,900
24,600
25,200
25,400
25,890
25,900
26,200
26,600
27,504
28,360
29,185
30,020
30,500
28,786
28,825
29,110
29,833
29,732
29,294
29,586
30,198
30,135
29,834
30,166
31,516
30,834
31,800
31,303
31,783
31,783
32,488
33,814
34,517
34,517
35,645
35,645
32,157
30,270
30,270
34,443
18,810
18,810
18,419
18,185
11,746
11,746
13,570
14,325
15,026
15,649
17,371
18,420
19,427
19,909
21,172
21,583
22,426
24,261
24,767
23,761
21,905
23,127
24,226
25,078
25,854
26,568
25,719
25,621
33,736
33,736
33,231
32,820
33,688
34,189
34,516
34,552
39,160
39,844
37,590
35,102
30,522
27,255
24,433
32,609
29,961
27,443
25,629
23,988
22,705
21,149
18,794
17,252
17,366
25,649
26,880
25,322
23,299
21,326
19,432
18,075
17,231
15,884
13,450
12,064
9,522
9,52212,06413,45015,88417,23118,07519,43221,32623,29925,32226,88025,64917,36617,25218,79421,14922,70523,98825,62927,44329,96132,60924,43327,25530,52235,10237,59039,84439,16034,55234,51634,18933,68832,82033,23133,73633,73625,62125,71926,56825,85425,07824,22623,12721,90523,76124,76724,26122,42621,58321,17219,90919,42718,42017,37115,64915,02614,32513,57011,74611,74618,18518,41918,81018,81034,44330,27030,27032,15735,64535,64534,51734,51733,81432,48831,78331,78331,30331,80030,83431,51630,16629,83430,13530,19829,58629,29429,73229,83329,11028,82528,78630,50030,02029,18528,36027,50426,60026,20025,90025,89025,40025,20024,60023,90023,00022,20021,70021,50020,90020,70004,700000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
70
70
70
70
100
100
66
66
67
68
67
68
68
69
69
70
70
70
70
70
70
70
73
70
73
74
74
74
75
76
76
76
78
78
79
83
83
83
89
89
89
89
89
89
89
89
89
89
89
89
89
91
92
92
92
93
93
94
94
95
102
103
104
105
106
107
108
108
110
110
111
111
112
112
124
126
126
126
126
126
126
145
145
145
147
147
147
147
148
148
148
165
167
168
168
168
169
169
169
169
171
172
172
172172171169169169169168168168167165148148148147147147147145145145126126126126126126124112112111111110110108108107106105104103102959494939392929291898989898989898989898989898383837978787676767574747473707370707070707070696968686768676666100100707070700000000000000
   Retained Earnings Total Equity000-71,56200000-59,726-57,561-58,954-56,944-56,765-55,046-52,266-50,615-49,054-47,269-44,850-41,802-38,946-35,872-32,592-28,989-23,834-20,738-17,988-16,122-5,307-4,636-4,308-16,122-4,847-5,289-4,637-4,883-13,647-14,137-14,434-14,921-15,333-15,863-16,278-17,152-17,394-16,649-16,985-18,590-19,376-19,72500000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-400
-700
-700
-700
-800
-900
-1,100
0
10
20
20
-20
0
-2
-3
-2
3
10
13
8
6
3
1
-2
3
3
1
-1
-1
-8
-1
-29
-20
-80
-35
-48
-44
-5,744
-27
-20
-5
-20
-6,286
-9
-25
-180
-88
-89
-238
-380
-192
-196
-233
-212
-216
-205
-212
-205
-228
-68
-48
-35
-8,325
0
0
-8,560
-8,560
0
0
0
0
0
0
-9,200
-9,200
0
0
0
0
0
0
-10,335
-10,335
0
0
0
23
41
127
70
78
66
102
80
82
73
32
-19
19
9
29
45
73
129
188
-24
-35
-40
-19
-52
-52-19-40-35-24188129734529919-19327382801026678701274123000-10,335-10,335000000-9,200-9,200000000-8,560-8,56000-8,325-35-48-68-228-205-212-205-216-212-233-196-192-380-238-89-88-180-25-9-6,286-20-5-20-27-5,744-44-48-35-80-20-29-1-8-1-1133-2136813103-2-3-20-202020100-1,100-900-800-700-700-700-400000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,699
41,861
42,032
42,414
42,692
42,712
38,958
39,305
39,987
40,308
40,671
40,897
39,750
39,161
38,511
38,538
38,410
37,557
55,158
38,386
39,040
39,747
55,158
57,706
58,202
58,810
59,385
59,698
60,138
71,283
71,548
72,070
72,685
72,793
73,093
73,186
73,619
73,837
74,181
84,419
84,265
84,851
0
0
0
0
0
87,312
0
0
0
00087,3120000084,85184,26584,41974,18173,83773,61973,18673,09372,79372,68572,07071,54871,28360,13859,69859,38558,81058,20257,70655,15839,74739,04038,38655,15837,55738,41038,53838,51139,16139,75040,89740,67140,30839,98739,30538,95842,71242,69242,41442,03241,86141,69900000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000-1,656-1,374-1,266-1,078-951-831-733-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-430-35600000000000000000000000000
   Other Stockholders Equity 
0
0
0
5,500
0
21,100
21,500
22,000
22,000
22,000
22,300
22,500
22,800
21,730
21,780
21,790
21,790
21,680
21,700
22,110
22,260
22,060
25,570
22,360
25,958
25,986
22,610
22,990
23,090
23,100
23,190
23,201
23,222
23,222
23,293
24,173
23,470
24,345
24,558
0
24,851
25,158
25,600
0
25,904
0
27,845
29,267
0
32,305
38,070
0
38,265
38,492
38,657
0
38,675
39,081
39,227
39,390
39,532
40,429
40,575
40,738
40,675
40,868
40,910
40,954
41,148
41,318
41,056
38,958
39,305
39,987
40,308
40,671
40,897
39,750
39,161
0
47,711
38,410
37,557
37,986
38,386
39,040
39,747
65,493
57,706
58,202
58,810
59,385
59,698
60,138
71,283
71,548
72,070
72,685
72,793
73,093
73,186
73,619
73,837
74,181
84,419
84,265
84,851
85,255
85,645
85,935
86,286
86,802
87,312
87,647
87,993
88,444
88,44487,99387,64787,31286,80286,28685,93585,64585,25584,85184,26584,41974,18173,83773,61973,18673,09372,79372,68572,07071,54871,28360,13859,69859,38558,81058,20257,70665,49339,74739,04038,38637,98637,55738,41047,711039,16139,75040,89740,67140,30839,98739,30538,95841,05641,31841,14840,95440,91040,86840,67540,73840,57540,42939,53239,39039,22739,08138,675038,65738,49238,265038,07032,305029,26727,845025,904025,60025,15824,851024,55824,34523,47024,17323,29323,22223,22223,20123,19023,10023,09022,99022,61025,98625,95822,36025,57022,06022,26022,11021,70021,68021,79021,79021,78021,73022,80022,50022,30022,00022,00022,00021,50021,10005,500000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue51,869
Cost of Revenue-30,395
Gross Profit21,47421,474
 
Operating Income (+$)
Gross Profit21,474
Operating Expense-31,481
Operating Income-10,007-10,007
 
Operating Expense (+$)
Research Development6,559
Selling General Administrative8,748
Selling And Marketing Expenses16,237
Operating Expense31,48131,544
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-10,007
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,480-10,534
EBIT - interestExpense = -10,007
-9,480
-9,570
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-10,007-9,480
Earnings Before Interest and Taxes (EBITDA)-7,975
 
After tax Income (+$)
Income Before Tax-9,480
Tax Provision-90
Net Income From Continuing Ops-9,570-9,570
Net Income-9,570
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses61,876
Total Other Income/Expenses Net5270
 

Technical Analysis of Iridex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Iridex. The general trend of Iridex is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Iridex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IRIDEX Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.65.

The bearish price targets are: 2.69 > 2.29 > 1.89.

Tweet this
IRIDEX Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IRIDEX Corporation. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IRIDEX Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IRIDEX Corporation. The current macd is 0.06401392.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Iridex price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Iridex. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Iridex price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
IRIDEX Corporation Daily Moving Average Convergence/Divergence (MACD) ChartIRIDEX Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IRIDEX Corporation. The current adx is 25.01.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Iridex shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
IRIDEX Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IRIDEX Corporation. The current sar is 3.54673208.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IRIDEX Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IRIDEX Corporation. The current rsi is 48.60. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
IRIDEX Corporation Daily Relative Strength Index (RSI) ChartIRIDEX Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IRIDEX Corporation. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Iridex price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
IRIDEX Corporation Daily Stochastic Oscillator ChartIRIDEX Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IRIDEX Corporation. The current cci is -60.42625544.

IRIDEX Corporation Daily Commodity Channel Index (CCI) ChartIRIDEX Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IRIDEX Corporation. The current cmo is -9.98751338.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
IRIDEX Corporation Daily Chande Momentum Oscillator (CMO) ChartIRIDEX Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IRIDEX Corporation. The current willr is -89.87341772.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
IRIDEX Corporation Daily Williams %R ChartIRIDEX Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IRIDEX Corporation.

IRIDEX Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IRIDEX Corporation. The current atr is 0.2031643.

IRIDEX Corporation Daily Average True Range (ATR) ChartIRIDEX Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IRIDEX Corporation. The current obv is -614,276.

IRIDEX Corporation Daily On-Balance Volume (OBV) ChartIRIDEX Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IRIDEX Corporation. The current mfi is 62.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
IRIDEX Corporation Daily Money Flow Index (MFI) ChartIRIDEX Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IRIDEX Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

IRIDEX Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IRIDEX Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.596
Ma 20Greater thanMa 503.124
Ma 50Greater thanMa 1002.782
Ma 100Greater thanMa 2002.778
OpenGreater thanClose3.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Iridex with someone you think should read this too:
  • Are you bullish or bearish on Iridex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Iridex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IRIDEX Corporation

I send you an email if I find something interesting about IRIDEX Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about IRIDEX Corporation.

Receive notifications about IRIDEX Corporation in your mailbox!